Asaf Danziger
Chief Executive Officer at NovoCure Limited
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: NovoCure Limited, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
NovoCure Limited June 3, 202698.3%
-
NovoCure Limited June 4, 202599.1%
-
NovoCure Limited June 5, 202499.2%
-
NovoCure Limited June 7, 202399.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | NovoCure Limited | Grant or award | +268 | $11.15 | $2,988 |
| Dec 31, 2025 | NovoCure Limited | Grant or award | +1 | $10.99 | $11 |
| Jun 30, 2025 | NovoCure Limited | Grant or award | +833 | $15.13 | $12,603 |
| Jan 1, 2025 | NovoCure Limited | Grant or award | +400,000 | — | — |
| Dec 31, 2024 | NovoCure Limited | Grant or award | +412 | $14.75 | $6,077 |
| Jun 28, 2024 | NovoCure Limited | Grant or award | +1,239 | $12.24 | $15,165 |
| Jun 30, 2023 | NovoCure Limited | Grant or award | +367 | $35.28 | $12,948 |
| Jan 6, 2023 | NovoCure Limited | Grant or award | +39 | $62.31 | $2,430 |
| Jan 5, 2023 | NovoCure Limited | Option exercise | +25,000 | $11.46 | $286,500 |
| Jan 5, 2023 | NovoCure Limited | Open-market sale | −8,369 | $111.23 | $930,884 |
| Jan 5, 2023 | NovoCure Limited | Open-market sale | −2,000 | $112.86 | $225,720 |
| Jan 5, 2023 | NovoCure Limited | Open-market sale | −4,568 | $114.35 | $522,351 |
| Jan 5, 2023 | NovoCure Limited | Open-market sale | −3,702 | $115.21 | $426,507 |
| Jan 5, 2023 | NovoCure Limited | Open-market sale | −1,395 | $116.06 | $161,904 |
| Jan 5, 2023 | NovoCure Limited | Open-market sale | −999 | $117.01 | $116,893 |
Questions about Asaf Danziger
What boards is Asaf Danziger on?
Asaf Danziger sits on the board of NovoCure Limited.
What company is Asaf Danziger the CEO of?
Asaf Danziger is Chief Executive Officer of NovoCure Limited.
How long has Asaf Danziger served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.